The document is the FIRST unified output from the One Field Medical Excellence group as a consortium of cross-industry experts. The group is made up of senior medical leaders from 30+ companies and was established to support the continued achievement of medical excellence.
The need to demonstrate tangible measures of Field Medical impact is widely recognised as an ongoing challenge within the biopharma industry. The One FME group wanted to identify innovative and practical approaches to address the challenge from the perspective of the patient, external expert and company.
Creation of the document was a monumental challenge. We are hugely thankful to Victoria Ho for her drive and leadership and all contributors: Kate Bradford, Maja Beilmann-Schramm, Phil Carter, Andrew Dias, Lorna Fergusson, Lina Fusco, Niki A. Georgiou, PhD, Andreas Gerloff, Simon Harris, Andrew Hewitson, Helen Kane, Laurie Lowe, Drew Macgregor, Mark Macdonald, Steve Medhurst, PhD, Marc Van Melckenbeke, Hetal Patel PharmD, MBA, Jenny Quinn, Emma Rankine, Mark Rees-Saunders, Peter Smith, Jodi Tainton, Georgina Tilley (PhD), Leonardo Villalobos, Amanda Wan, Elaine Wilson, Lis Brøsted Zimmermann and Rumi (online collaboration and discussion platform).
Do you really want to log out?